IL6 and myeloproliferative neoplasm: Since we have previously shown that the levels of pro-inflammatory cytokine IL-6 are elevated in the plasma and bone marrow of MPN patients [12], in accordance with the JAK2V617F mutant allele burden, we also wanted to examine the total degree of its expression in the bone marrow of MPN patients.